On ECHEMI
Home > Drugs > EMeiShan Tonghui Pharmaceutical Co., Ltd.
EMeiShan Tonghui Pharmaceutical Co., Ltd.
  • Founded in:

    2002-03-29
  • Country:

    China China
  • Address:

    Tonghui Road, Processing, Warehousing and Logistics Park, Emeishan City
  • Tax NO.:

    91511181621167487U
  • Registered Funds:

    54.138461 yuan
  • Website:

  • Email:

Related Drugs
Vitamin C for injection
The main ingredient of this product is vitamin C, and its chemical name is L-ascorbic acid.
Name Description Content CAS NO. Registered Holders
Ascorbic Acid

It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell matrix, can reduce capillary permeability, accelerate blood coagulation, stimulate blood coagulation function, promote iron absorption in the intestine, promote blood lipid reduction, increase resistance to infection, participate in detoxification function, and has anti-histamine effect and prevents the formation of carcinogens (nitrosamines).

More

It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell matrix, can reduce capillary permeability, accelerate blood coagulation, stimulate blood coagulation function, promote iron absorption in the intestine, promote blood lipid reduction, increase resistance to infection, participate in detoxification function, and has anti-histamine effect and prevents the formation of carcinogens (nitrosamines).

50-81-7 28
Vitamin C for injection
The main ingredient of this product is vitamin C, and its chemical name is L-ascorbic acid.
Name Description Content CAS NO. Registered Holders
Ascorbic Acid

It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell matrix, can reduce capillary permeability, accelerate blood coagulation, stimulate blood coagulation function, promote iron absorption in the intestine, promote blood lipid reduction, increase resistance to infection, participate in detoxification function, and has anti-histamine effect and prevents the formation of carcinogens (nitrosamines).

More

It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell matrix, can reduce capillary permeability, accelerate blood coagulation, stimulate blood coagulation function, promote iron absorption in the intestine, promote blood lipid reduction, increase resistance to infection, participate in detoxification function, and has anti-histamine effect and prevents the formation of carcinogens (nitrosamines).

50-81-7 28
Atenolol Tablets
The main chemical component is Atenolol. The chemical name is 4-[3-[(1-methylethyl)amino-2-hydroxy]propoxy]phenylacetamide
Name Description Content CAS NO. Registered Holders
Atinol

It is a selective β1-adrenergic receptor blocker with no membrane stabilizing effect and endogenous sympathomimetic activity. However, it does not inhibit the bronchodilator effect of isoproterenol. Its mechanism of lowering blood pressure and reducing myocardial oxygen consumption is the same as that of propranolol. Large-scale clinical trials have confirmed that atenolol can reduce the mortality rate of acute myocardial infarction within 0 to 7 days. The therapeutic dose has no significant inhibition on myocardial contractility.

More

It is a selective β1-adrenergic receptor blocker with no membrane stabilizing effect and endogenous sympathomimetic activity. However, it does not inhibit the bronchodilator effect of isoproterenol. Its mechanism of lowering blood pressure and reducing myocardial oxygen consumption is the same as that of propranolol. Large-scale clinical trials have confirmed that atenolol can reduce the mortality rate of acute myocardial infarction within 0 to 7 days. The therapeutic dose has no significant inhibition on myocardial contractility.

0
Pamidronate Disodium for Injection
The chemical name is: 3-amino-1-hydroxypropylidene-1,1-diphosphonic acid disodium pentahydrate.
Name Description Content CAS NO. Registered Holders
3-amino-1-hydroxypropylidene-1,1-diphosphonic acid disodium pentahydrate

This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.

More

This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.

0
Cytidine Triphosphate Disodium for Injection
The main ingredients of this product and their chemical names are: Cytidine triphosphate disodium. Cytosine nucleoside-5-triphosphate disodium.
Name Description Content CAS NO. Registered Holders
Cytidine 5'-triphosphate disodium salt

Cytidine triphosphate disodium is a coenzyme drug and a nucleotide derivative. It participates in the synthesis and metabolism of phospholipids and nucleic acids in the body. It is an intermediate product and energy source for brain phospholipid synthesis and nucleic acid metabolism.

More

Cytidine triphosphate disodium is a coenzyme drug and a nucleotide derivative. It participates in the synthesis and metabolism of phospholipids and nucleic acids in the body. It is an intermediate product and energy source for brain phospholipid synthesis and nucleic acid metabolism.

36051-68-0 10
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.